- Home
- NWSA vs ICLR Comparison
NWSA vs ICLR Comparison
Compare NWSA & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NWSA
- ICLR
- Stock Information
- Founded
- NWSA 2012
- ICLR 1990
- Country
- NWSA United States
- ICLR Ireland
- Employees
- NWSA N/A
- ICLR N/A
- Industry
- NWSA Newspapers/Magazines
- ICLR Biotechnology: Commercial Physical & Biological Resarch
- Sector
- NWSA Consumer Discretionary
- ICLR Health Care
- Exchange
- NWSA Nasdaq
- ICLR Nasdaq
- Market Cap
- NWSA 16.6B
- ICLR 14.5B
- IPO Year
- NWSA N/A
- ICLR 1998
- Fundamental
- Price
- NWSA $29.46
- ICLR $175.84
- Analyst Decision
- NWSA Strong Buy
- ICLR Buy
- Analyst Count
- NWSA 7
- ICLR 13
- Target Price
- NWSA $37.78
- ICLR $211.92
- AVG Volume (30 Days)
- NWSA 3.5M
- ICLR 1.7M
- Earning Date
- NWSA 08-05-2025
- ICLR 07-23-2025
- Dividend Yield
- NWSA 0.68%
- ICLR N/A
- EPS Growth
- NWSA 345.01
- ICLR 13.11
- EPS
- NWSA 2.07
- ICLR 9.73
- Revenue
- NWSA $8,452,000,000.00
- ICLR $8,089,820,000.00
- Revenue This Year
- NWSA $5.56
- ICLR N/A
- Revenue Next Year
- NWSA $3.60
- ICLR $1.72
- P/E Ratio
- NWSA $35.08
- ICLR $18.06
- Revenue Growth
- NWSA 2.42
- ICLR N/A
- 52 Week Low
- NWSA $23.38
- ICLR $125.10
- 52 Week High
- NWSA $30.75
- ICLR $328.35
- Technical
- Relative Strength Index (RSI)
- NWSA 53.13
- ICLR 59.78
- Support Level
- NWSA $28.21
- ICLR $154.97
- Resistance Level
- NWSA $29.98
- ICLR $176.81
- Average True Range (ATR)
- NWSA 0.63
- ICLR 6.28
- MACD
- NWSA 0.02
- ICLR 0.00
- Stochastic Oscillator
- NWSA 65.50
- ICLR 61.13
About NWSA News Corporation
News Corporation is a diversified media conglomerate with significant presence in the US, the UK, and Australia. Key mastheads include The Wall Street Journal, Barron's, New York Post, The Times, The Sun, The Australian, Herald Sun, and The Daily Telegraph. Its 61%-owned REA Group is the dominant property listings business in Australia. In addition, it owns Harper Collins, one of the largest book publishers in the world, and has a sizable US digital property advertising business, Move. The 65% interest in Foxtel, the Australian pay-TV and streaming provider, was sold in April 2025. The sale to global sports streaming platform, DAZN, was struck at more than 7 times Foxtel's EBITDA.
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.